Ancora Advisors’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,500
Closed -$115 1998
2023
Q1
$115 Hold
2,500
﹤0.01% 1880
2022
Q4
$0 Hold
2,500
﹤0.01% 2223
2022
Q3
$0 Hold
2,500
﹤0.01% 2361
2022
Q2
$0 Hold
2,500
﹤0.01% 2520
2022
Q1
$1K Buy
+2,500
New +$911 ﹤0.01% 2335

Ancora Advisors's IQMDW Position: Q2 2023 in Review

Ancora Advisors sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 2,500 shares — an estimated $115 sold.

Ancora Advisors first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

  • Ancora Advisors reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Ancora Advisors sold 2,500 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $115.
  • Ancora Advisors first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
  • Ancora Advisors's Intelligent Medicine Acquisition Corp. Warrant position peaked at $1K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.